Merola R, Mottolese M, Orlandi G, Vico E, Cognetti F, Sperduti I, Fabi A, Vitelli G, Cianciulli A M
Department of Clinical Pathology (Cytogenetic Unit), Regina Elena Cancer Institute, Via Elio Chianesi, 53, 00144 Rome, Italy.
Eur J Cancer. 2006 Jul;42(10):1501-6. doi: 10.1016/j.ejca.2006.03.011. Epub 2006 Jun 9.
Our aim was to determine the aneusomy level and the HER-2 gene copy numbers, by fluorescence in situ hybridization (FISH) and to analyze their impact on the amplification rate in breast carcinomas considered HER-2 weakly positive cases by immunohistochemistry. We evaluated 343 breast carcinomas using double colour FISH (LSI Her-2/neu gene and CEP 17). Monosomy and polysomy were demonstrated in 24.2% and 46.1% respectively and 101/343 (29.6%) of the specimens were amplified by FISH. A statistically significant difference was observed, when we compared the amplification percentage in polysomic and monosomic specimens (P<0.0001) and, among polysomic specimens, when tumours were compared with HER-2 gene signals number per cell between 3 and 10 and >10 respectively (P<0.0001). Logistic regression analysis showed that HER-2 signals >10 and polysomy absence were independently associated with amplification. Our results confirm that the majority of 2+ IHC cases express the HER-2 protein without gene amplification and highlight the effect of chromosome 17 aneusomy and the HER-2 gene copy number on amplification.
我们的目的是通过荧光原位杂交(FISH)确定非整倍体水平和HER-2基因拷贝数,并分析它们对免疫组化检测为HER-2弱阳性的乳腺癌扩增率的影响。我们使用双色FISH(LSI Her-2/neu基因和CEP 17)评估了343例乳腺癌。分别有24.2%和46.1%的病例表现为单体型和多体型,101/343(29.6%)的标本通过FISH检测为扩增型。当我们比较多体型和单体型标本的扩增百分比时,观察到统计学上的显著差异(P<0.0001),并且在多体型标本中,当分别比较肿瘤细胞中HER-2基因信号数在3至10之间和>10之间的情况时,也观察到显著差异(P<0.0001)。逻辑回归分析表明,HER-2信号>10和不存在多体型与扩增独立相关。我们的结果证实,大多数免疫组化2+病例表达HER-2蛋白但无基因扩增,并突出了17号染色体非整倍体和HER-2基因拷贝数对扩增的影响。